Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

MGC Diagnostics Corporation to Report Third Quarter Fiscal Year 2016 Financial Results on Wednesday, September 7, 2016

MGC Diagnostics Corporation
Posted on: 31 Aug 16

PR Newswire

SAINT PAUL, Minn., Aug. 31, 2016

SAINT PAUL, Minn., Aug. 31, 2016 /PRNewswire/ -- MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the third quarter fiscal year 2016, ended July 31, 2016. The call will be at 4:30 p.m. ET on Wednesday, September 7, 2016. The Company will report financial results for the third quarter fiscal year 2016 after the markets close on Wednesday, September 7, 2016.

Participants can dial (844) 861-5496 or (412) 317-6578 to access the conference call, or listen via a live Internet webcast on the Company's website at A replay of the conference call will be available by dialing (877) 344-7529 or (412) 317-0088, confirmation code 10091838, through September 14, 2016. A webcast replay of the conference call will be accessible on the Company's website at for 90 days.

About MGC Diagnostics

MGC Diagnostics Corporation (NASDAQ: MGCD) is a global medical technology company dedicated to cardiorespiratory health solutions. The Company, through its Medical Graphics Corporation and Medisoft SA subsidiaries, develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit


Wesley W. Winnekins           

Joe Dorame, Robert Blum, Joe Diaz

MGC Diagnostics Corporation  

Lytham Partners, LLC

Chief Financial Officer              

(602) 889-9700

(651) 484-4874           


To view the original version on PR Newswire, visit:

SOURCE MGC Diagnostics Corporation

PR Newswire

Last updated on: 31/08/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.